SZSE: 301408 - Anhui Huaren Health Pharmaceutical Co., Ltd.

Yield per half year: -24.52%
Dividend yield: 0.00%
Sector: Healthcare

Reporting Anhui Huaren Health Pharmaceutical Co., Ltd.

Capitalization

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Капитализация, млрд ¥
6.73
Выручка, млрд ¥
3.43
Чистая прибыль, млрд ¥
0.1748
EV, млрд ¥
6.1
EBITDA, млрд ¥
0.2084


Balance sheet

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Наличность, млрд ¥
1.32
Долг, млрд ¥
0.6854


Share

IFRS
Reporting Annual Quarterly
2023 2024 LTM 5 year average CAGR 5
EPS 0.2866 0.5
Цена акции ао 18.29 9.39 9.39


Efficiency

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROS, % 5.1 5.1 5.1 5.1 23.77
ROCE, % 0 0 0.00
Ebit margin, % 0 0
Рентаб EBITDA, % 6.08 6.08 28.48
Чистая рентаб, % 5.09 23.79
Operation Margin, % 0 0 0 0 0.00


Coefficients

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
33.21 33.38
P/BV
3.62 5.66
P/S
1.7 9.95
P/FCF
0 0 0 0 0.00
E/P
0.026 0.026 0.026 0.026 0.04
EV/EBITDA
23.96 25.59
EV/EBIT
0 0 0
EV/S
1.78 1.78 1.78 1.78 9.50
EV/FCF
0 0 0 0.00
Debt/EBITDA
3.29 3.29 3.29 3.29 0.59
Netdebt/Ebitda
0 0 0 0 0.00
Debt/Ratio
0 0 0 0 0.00
Debt/Equity
0 0 0 0 0.00
Debt/Net Income
3.92 3.92 3.92 3.92 0.75
Бета
0 -0.3663 0 0 0.00
Индекс Альтмана
0 0 0 0 0.00


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденды / прибыль, %
0 29.29


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
5785 5785